Tracing Metabolic Flux In Vivo with Stable Isotopes

Il Young Kim, Ph.D., is an Associate Professor (since March 2021) in the Department of Molecular Medicine at the Lee Gil Ya Cancer and Diabetes Institute, College of Medicine, Gachon University, South Korea. He is the Chief Executive Officer of Myocare Inc. (since October 1, 2021), a company focused on muscle functional foods and both in vivo and in vitro metabolic flux analysis. Professor Kim earned his Ph.D. in Exercise Physiology and Metabolism at the University of Texas at Austin and was trained for clinical metabolism using stable isotope tracers under the guidance of Prof. Robert Wolfe and worked as Assistant Professor at the Center for Translational Research in Aging & Longevity, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences from 2012 June and 2027 Nov. His current research interest is on the in-depth understanding of in vivo metabolic alterations in relation to various aspects of human (animal) pathophysiology and normal physiology in combination with exercise, nutrition, drugs, etc. by using stable isotope tracer methodology.

Charles Davis presently serves as Sr. Product Manager for the Deuterium-Labeled portfolio within the Merck KGaA Darmstadt, Germany Life Sciences Stable Isotopes business unit. His current focus is growing customer partnerships and driving expansion of internal capacity to deliver scaled and customized Deuterium-labeled solutions.  He earned a PhD in Chemistry from the University of Iowa, focusing on new synthetic methodology utilizing fluorinated organometallic reagents, followed by a post-doctoral appointment at Pharmacia.  With over 20 years’ experience in chemical industry, he has held roles in Product Management, Business Development, Production Plant Management, Deuterium-Labeled Production, and Project Management.